Skip to main content

Alfons Macaya Ruíz

Institutions of which they are part

Main researcher
Therapeutics and Innovations in Neuropediatrics and other paediatric rare diseases
Vall Hebron Institut de Recerca

Alfons Macaya Ruíz

Institutions of which they are part

Main researcher
Therapeutics and Innovations in Neuropediatrics and other paediatric rare diseases
Vall Hebron Institut de Recerca

Research lines

Pediatric neurogenetics

Neurogenetics of paroxysmal neurological disorders (neuronal channelopathies)

Genetic and epigenetic basis of neural tube defects and Chiari type I malformation 

Clinical researchers have collected samples from more than 2000 patients with paroxysmal neurological disorders (migraine, epilepsy, paroxysmal movement disorders and episodic ataxias) and over 300 patients with Chiari I malformation. Current strategies include whole-genome linkage analysis, exome sequencing, customized array re-sequencing, SNP-based genetic association studies and expression analysis in fetal tissues. The goals in this area are:


- to identify novel genetic variants responsible for these diseases

- to establish a correlation between the genetic variants and the clinical forms of the disease

- to perform functional studies of the mutant proteins

- to design an animal model of cortical spreading depression, with emphasis in epigenetic modification of susceptibility genes.


IP: Alfons Macaya Ruíz

Projects

KIDS Vall d'Hebron: Jóvenes Impulsando la Ciencia Ciudadana y la Comunicación Científica

IP: Lucas Moreno Martín-Retortillo
Collaborators: Marina Martínez Jiménez, Alfons Macaya Ruíz, Anna Santamaria Margalef, Pere Soler Palacín, Ana Marti Delgado, Sara Mas Assens, Immaculada Hernández Rodríguez
Funding agency: Fundación Española Ciencia y Tecnología (FECYT)
Funding: 25000
Reference: FCT-24-21771
Duration: 01/09/2025 - 31/08/2026

Neurologia infantil

IP: Alfons Macaya Ruíz
Collaborators: Laia Ventura i Expósito, Belen Perez Dueñas, Laura Costa Comellas, Francina Munell Casadesus, Anna Marcé Grau, Miquel Raspall Chaure, Mireia Del Toro Riera, Julia Sala Coromina, Ana Felipe Rucián, Neurologia infantil, David Gómez Andrés, Amaia Lasa Aranzasti, Lucy Dougherty de Miguel
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 01171
Duration: 01/01/2022 - 30/06/2025

Evaluation of NGS candidate genes causality in developmental epileptic encephalopathiea

IP: Alfons Macaya Ruíz
Collaborators: Anna Marcé Grau, Miquel Raspall Chaure, Mireia Del Toro Riera, Julia Sala Coromina, Ana Felipe Rucián
Funding agency: Instituto de Salud Carlos III
Funding: 196020
Reference: PI20/01803
Duration: 01/01/2021 - 31/12/2023

Xarxa R+D+I AGAUR - Acuerdo HUB D’INNOVACIÓ PEDIÀTRICA

IP: Alfons Macaya Ruíz
Collaborators: -
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: AGAUR/XARXES/2018/MACAYA
Duration: 09/04/2020 - 31/12/2023

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

Over the course of one week, it will host in-person assessments for 35 families to better understand the progression of the disease and contribute to the development of new therapies.

The event focused on advances in disease-modifying therapies and on the value of alliances between patients and professionals to promote more participatory care and research.

Related professionals

Laura Gonzalez Garcia

Laura Gonzalez Garcia

Growth and Development
Read more
Montserrat Aran Esteve

Montserrat Aran Esteve

Main researcher
Multidisciplinary Nursing Research Group
Read more
Ana García de Frutos

Ana García de Frutos

Predoctoral researcher
Spine Research Unit
Read more
Carme Santoyo Medina

Carme Santoyo Medina

Main researcher
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.